Orchard Therapeutics, a leading commercial-stage biotech company dedicated to transforming the lives of patients with rare diseases through innovative gene therapies, today announced the appointment …

Proceeds raised from the issuance will be used for clinical trials, working capital needs and further development of the company’s pipeline of biosimilar treatments. JHL …

In her new role, Ms. Wang will lead the clinical operations in Asia Pacific and work closely with global research and development teams to advance …